<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="case-report" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Our Dermatol Online</journal-id>
<journal-title>Our Dermatol Online</journal-title>
<issn pub-type="epub">2081-9390</issn>
<publisher>
<publisher-name>Our Dermatology Online</publisher-name>
<publisher-loc>Poland</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">OURD-8-296</article-id>
<article-id pub-id-type="doi">10.7241/ourd.20173.85</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>De novo</italic> anaplastic Kaposi sarcoma in a HIV-negative man: A case report and review of the literature</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Charfi</surname>
<given-names>Slim</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
<xref ref-type="corresp" rid="cor1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chaabane</surname>
<given-names>Hend</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chaari</surname>
<given-names>Ikbel</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kallel</surname>
<given-names>Rim</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Turki</surname>
<given-names>Hamida</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Boudawara</surname>
<given-names>Tahya Sellami</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><italic>Department of Pathology, CHU Habib Bourguiba, Sfax, Tunisie</italic></aff>
<aff id="aff2"><label>2</label><italic>Department of Dermatology, CHU Hedi Chaker, Sfax, Tunisie</italic></aff>
<author-notes>
<corresp id="cor1">
<bold>Corresponding author:</bold> Prof. Slim Charfi, E-mail: <email xlink:href="charfislim@gmail.com">charfislim@gmail.com</email>
</corresp>
</author-notes>
<pub-date pub-type="ppub">
<year>2017</year>
</pub-date>
<volume>8</volume>
<issue>3</issue>
<fpage>296</fpage>
<lpage>299</lpage>
<history>
<date date-type="received"><day>18</day><month>09</month><year>2016</year></date>
<date date-type="accepted"><day>24</day><month>11</month><year>2016</year></date>
</history>
<permissions>
<copyright-statement>Copyright: &#x000a9; Our Dermatol Online 3</copyright-statement>
<copyright-year>2017</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
</license>
</permissions>
<abstract>
<p>Anaplastic Kaposi sarcoma is a rare variant of Kaposi&#x2019;s and is typically associated with an agressive clinical course. We report a case of a 67-year-old HIV negative man, presented with multiple, pink nodules on the left ankle and a keratotic lesion of the right heel. Initial histopathological exam concluded to an undifferentiated sarcoma. A second biopsy was performed and concluded to an anaplastic Kaposi sarcoma. Immunohistochemical study was positive for HHV8. Treatment consisted on a tumor excision of all lesions. Our case and the review of the literature highlight the benefit of the non conservative surgical treatment for this aggressive form of Kaposi sarcoma.</p>
</abstract>
<kwd-group>
<kwd>Anaplastic</kwd>
<kwd>Kaposi</kwd>
<kwd>Prognosis</kwd>
<kwd>Pathology</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-1" sec-type="intro">
<title>INTRODUCTION</title>
<p>Kaposi sarcoma has the ability to develop into lesions of varying morphologic appearance. Anaplastic variant is the only variant associated with aggressive behaviour [<xref ref-type="bibr" rid="ref1">1</xref>]. It is important to be able to recognize this variant in order to avoid potential misdiagnosis and improper management of affected patients. We present here a case of anaplastic KS in a HIV negative patient and a review of literature about anaplastic KS.</p>
</sec>
<sec id="sec1-2" sec-type="cases">
<title>CASE REPORT</title>
<p>A 67-year-old man with a history of type 2 diabetes, high blood pressure and deep vein thombosis of the left lower leg presented with multiple 0.5-2 cm, pink nodules, located on the left ankle. On the right heel, we noted akeratotic nodular lesion (<xref ref-type="fig" rid="F1">Fig. 1</xref>). All these lesions had a 2 months history. No lesions were noted in the oral mucosa. Laboratory test showed a biological inflammatory syndrome. HIV serology was negative. Clinical impression was that of Kaposi sarcoma and a punch biopsy of lesions was performed. Pathological report, peformed outside of our department concluded to an undifferentiated sarcoma. A second excisional biopsy was performed. Histopathological exam revealed an epidermal ulceration and dermal proliferation of spindle and epithelioid cells. Tumor cells are arranged in fascicles and solid sheets (<xref ref-type="fig" rid="F2">Fig. 2</xref>). Irregular vascular spaces, suggestive of a vasoformative tumor, were focally noted. There are areas of necrosis. The nuclei were very pleomorphic with variably prominent nucleoli. Numerous mitosis were present (10 mitosis per 10 HPF). The stromal component included numerous plasma cells. Immunohistochemical study showed positivity for CD34, CD31 and HHV8 (<xref ref-type="fig" rid="F3">Fig. 3</xref>). The diagnosis of anaplastic KS was made. Additional clinical workup including chest radiography, abdominal ultrasound and computed tomography scan of the chest, abdomen and pelvis were normal. Upper digestive endoscopy was not performed. Treatment has consisted on a complete electrosurgical shave tumor excision. At 13 months of follow-up, the patient was readmitted to our department for a disease progression with a fungiform exophytic mass of the left ankle (<xref ref-type="fig" rid="F4">Fig. 4</xref>). No distant metastatic recurrence was noted. A chemotherapy treatment was instaured.</p>
<fig id="F1">
<label>Figure 1</label>
<caption>
<p>Multiple round to oval, pink nodules on the left ankle; keratotic nodular lesion of the right heel.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-8-296-g001.tif"/>
</fig>
<fig id="F2">
<label>Figure 2</label>
<caption>
<p>Solid hapharzard proliferation of atypical spindle cells. (HE x 100).</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-8-296-g002.tif"/>
</fig>
<fig id="F3">
<label>Figure 3</label>
<caption>
<p>Positive immunohistochemical staining with HHV8. (HE x 400).</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-8-296-g003.tif"/>
</fig>
<fig id="F4">
<label>Fig. 4</label>
<caption>
<p>Fungiform exophytic mass of the left ankle.</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-8-296-g004.tif"/>
</fig>
</sec>
<sec id="sec1-3" sec-type="discussion">
<title>DISCUSSION</title>
<p>Anaplastic KS was first described in 1959 by Cox and Helwig as KS with increased in the number of mitotic figures and marked cellular pleomorphism [<xref ref-type="bibr" rid="ref2">2</xref>]. Anaplastic KS is an uncommon histologic variant, representing 0.4&#x0025; to 2.7&#x0025; of all the patients affected by KS [<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref5">5</xref>]. Clinical data regarding all published cases of anaplastic KS with confirmed HHV8 association are detailed in <xref ref-type="table" rid="T1">Table 1</xref>. Anaplastic KS arises in patients with a history of KS, or <italic>de novo</italic>. Factors that predispose to anaplastic progression of KS are not well known [<xref ref-type="bibr" rid="ref3">3</xref>]. Potential inducers, such as a long course of the disease, lymphedema, chemotherapy and immune system defects in HIV patients are reported [<xref ref-type="bibr" rid="ref4">4</xref>]. At the best of our knowledge only 14 <italic>de novo</italic> Anaplasic KS were published [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref5">5</xref>-<xref ref-type="bibr" rid="ref8">8</xref>]. Nine of these cases were reported by Ramdial et al. [<xref ref-type="bibr" rid="ref5">5</xref>]. Anaplastic histology has ben described in the context of classic, africain and AIDS-related KS [<xref ref-type="bibr" rid="ref1">1</xref>]. Anaplastic KS appear to have a predilection for acral location [<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref9">9</xref>,<xref ref-type="bibr" rid="ref10">10</xref>]. Only three HIV negative patients with <italic>de novo</italic> anaplastic KS, as our case, were reported [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref8">8</xref>].</p>
<table-wrap id="T1">
<label>Table 1</label>
<caption>
<p>Clinical data regarding all published cases of anaplastic Kaposi sarcoma with confirmed HHV8 association</p>
</caption>
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="OURD-8-296-g005.tif"/>
</table-wrap>
<p>Clinical presentation of anaplastic KS is not specific; they present as pink to purple or reddish cutaneous nodules and/or plaques [<xref ref-type="bibr" rid="ref4">4</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Some authors reported nodular areas growing rapidly to form a confluent fungiform exophytic mass that was in part ulcerated and necrotic [<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref5">5</xref>]. Infiltration of the muscle or bone was described [<xref ref-type="bibr" rid="ref4">4</xref>]. Salameire et al. report a case of 50-year-old woman who presented with several nodules on lymphedematous arm, 2 yeras after a left mastectomy and a homolateral lymphadenectomy, mimicking a stewart-treves syndrome [<xref ref-type="bibr" rid="ref8">8</xref>].</p>
<p>Anaplastic KS dispalys a significantly greater degree of nuclear and cellular pleomorphism than conventional nodular KS [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref11">11</xref>]. In addition, there is an increased mitotic activity (mitotic figures range from 10 to 20 per 10 hpf) and atypical mitosis may be encountered (radu, grayson). Necrosis is occasionally noted [<xref ref-type="bibr" rid="ref9">9</xref>]. The stromal component, like that of classical KS and as reported in our case is plasma cell-rich and contains extravasated erythrocytes [<xref ref-type="bibr" rid="ref7">7</xref>]. The vasoformative nature of anaplastic KS is not readly apparent. As in our report, Ramdial et al. reported three cases of anaplastic KS with initial erronous diagnosis (malignant peripheral nerve sheath tumor in two cases and metastatic melanoma in one case). In fact, many other malignant spindle cell neoplasms might be entertained in the histologic differential diagnosis of anaplastic KS. It includes certain sarcomas (leiomyosarcoma, spindle cell rhabdomyosarcoma, malignant peripheral nerve sheath tumor, fibrosarcoma), amelanotic spindle cell melanoma, especially when present on acral sites andspindle cell carcinoma [<xref ref-type="bibr" rid="ref5">5</xref>]. Angiosarcoma must also be considered, particularly if erythrocytes are identified between the markedly atypical spindled cells [<xref ref-type="bibr" rid="ref9">9</xref>]. A panel of immunohistochemical stains is often required to confirm the diagnosis of anaplastic KS. This panel must include HHV8. Immunostaining for S100 protein can lead to diagnostic pitfalls; in fact Ramdial et al demonstrates the presence of S100 positive cells corresponding to langerhans cells in anapalstic KS [<xref ref-type="bibr" rid="ref5">5</xref>].</p>
<p>Anaplastic KS is clinically associated with high local aggressiveness, deep invasion and increased metastatic behavior [<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref3">3</xref>,<xref ref-type="bibr" rid="ref7">7</xref>]. Considering our case and those described in the literature, we observe that among 28 patients with anaplastic KS, 9 died of anaplastic KS, 7 died of other causes (including four HIV positive patients) and 2 were alive with anaplastic KS [<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref7">7</xref>-<xref ref-type="bibr" rid="ref10">10</xref>,<xref ref-type="bibr" rid="ref12">12</xref>]. Satta et al. supported an intrinsic genetic instability of the malignant cell resulting in clonal progression of the neoplastic phenotype [<xref ref-type="bibr" rid="ref3">3</xref>]. Craddock et al. reports that anaplastic portion of the KS respond well to paclitaxel and no liposomal doxorubicin, while the background typical KS lesions have had the opposite behaviour with these two therapies [<xref ref-type="bibr" rid="ref9">9</xref>]. In the report of Salameire et al, a total regression of the lesion was obtained by elastic contention and intradermic liposomal doxorubicin [<xref ref-type="bibr" rid="ref8">8</xref>]. Tourlaki et al recommend an aggressive approch, more specifically a non-conservative surgical treatment associated with systemic chemotherapy. Amputation due to deep tissue invasion may be required [<xref ref-type="bibr" rid="ref4">4</xref>]. Our patient treated with only tumor excision, a frankly disease progression was noted at 13 months of diagnosis.</p>
<p>Anaplastic variant of KS is a poorly recognized associated to an aggressive clinical course and poor prognosis. Histopathological differential diagnoses include numerous undifferentiated high grade malignancies. Non conservative surgical treatment seems appropriate for these patients.</p>
<sec id="sec2-1">
<title>Consent</title>
<p>The examination of the patient was conducted according to the Declaration of Helsinki principles.</p>
</sec>
</sec>
</body>
<back>
<ref-list>
<title>REFERENCES</title>
<ref id="ref1">
<label>1</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grayson</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Pantanowitz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Histological variants of cutaneous Kaposi sarcoma</article-title>
<source>Diagn Pathol</source>
<year>2008</year>
<volume>3</volume>
<fpage>31</fpage>
</nlm-citation>
</ref>
<ref id="ref2">
<label>2</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cox</surname>
<given-names>FH</given-names>
</name>
<name>
<surname>Helwig</surname>
<given-names>EB</given-names>
</name>
</person-group>
<article-title>Kaposi&#x2019;s sarcoma</article-title>
<source>Cancer</source>
<year>1959</year>
<volume>12</volume>
<fpage>289</fpage>
<lpage>98</lpage>
</nlm-citation>
</ref>
<ref id="ref3">
<label>3</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Satta</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Cossu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Massarelli</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Cottoni</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>Anaplastic transformation of classic Kaposi&#x2019;s sarcoma:clinicopathological study of five cases</article-title>
<source>Br J Dermatol</source>
<year>2001</year>
<volume>145</volume>
<fpage>847</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref4">
<label>4</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tourlaki</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Recalcati</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boneschi</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Gaiani</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group>
<article-title>Anaplastic Kaposi&#x2019;s sarcoma:a study of eight patients</article-title>
<source>Eur J Dermatol</source>
<year>2013</year>
<volume>23</volume>
<fpage>382</fpage>
<lpage>6</lpage>
</nlm-citation>
</ref>
<ref id="ref5">
<label>5</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramdial</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Sing</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Naicker</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Calonje</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sewram</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Langerhans cells in anaplastic Kaposi sarcoma with a paucivascular phenotype:a potential diagnostic pitfall</article-title>
<source>Pathol Int</source>
<year>2011</year>
<volume>61</volume>
<fpage>221</fpage>
<lpage>7</lpage>
</nlm-citation>
</ref>
<ref id="ref6">
<label>6</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Skelton</surname>
<given-names>HG</given-names>
<suffix>3rd</suffix>
</name>
<name>
<surname>James</surname>
<given-names>WD</given-names>
</name>
<name>
<surname>Barrett</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Anderson</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>Angritt</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Angiosarcoma arising in Kaposi&#x2019;s sarcoma (pleomorphic Kaposi&#x2019;s sarcoma) in a patient with human immunodeficiency virus disease. Armed Forces Retroviral Research Group</article-title>
<source>J Am Acad Dermatol</source>
<year>1991</year>
<volume>24</volume>
<fpage>790</fpage>
<lpage>2</lpage>
</nlm-citation>
</ref>
<ref id="ref7">
<label>7</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Demierre</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Mahalingam</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Anaplastic Kaposi&#x2019;s sarcoma:an uncommonhistologic phenotype with an aggressive clinical course</article-title>
<source>J Cutan Pathol</source>
<year>2010</year>
<volume>37</volume>
<fpage>1088</fpage>
<lpage>91</lpage>
</nlm-citation>
</ref>
<ref id="ref8">
<label>8</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salameire</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Templier</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Charles</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pinel</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Morand</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Leccia</surname>
<given-names>MT</given-names>
</name>
<etal/>
</person-group>
<article-title>An &#x201C;anaplastic&#x201D; Kaposi&#x2019;s sarcoma mimicking a Stewart-Treves syndrome. A case report and a review of literature</article-title>
<source>Am J Dermatopathol</source>
<year>2008</year>
<volume>30</volume>
<fpage>265</fpage>
<lpage>8</lpage>
</nlm-citation>
</ref>
<ref id="ref9">
<label>9</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Craddock</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Labonte</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ghazarian</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Anaplastic Kaposi sarcoma resembling epithelioid angiosarcoma in an HIV-positive man</article-title>
<source>Eur J Dermatol</source>
<year>2008</year>
<volume>18</volume>
<fpage>358</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
<ref id="ref10">
<label>10</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gambassi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Semeraro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Suma</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Sebastio</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Incalzi</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Behavior of Classical Kaposi&#x2019;s Sarcoma and Coexistence With Angiosarcoma</article-title>
<source>J Gerontol A Biol Sci Med</source>
<year>2005</year>
<volume>4</volume>
<fpage>520</fpage>
<lpage>3</lpage>
</nlm-citation>
</ref>
<ref id="ref11">
<label>11</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radu</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Pantanowitz</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Kaposi sarcoma</article-title>
<source>Arch Pathol Lab Med</source>
<year>2013</year>
<volume>137</volume>
<fpage>289</fpage>
<lpage>94</lpage>
</nlm-citation>
</ref>
<ref id="ref12">
<label>12</label>
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerimele</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carlesimo</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Fadda</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rotoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cavalieri</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Anaplastic progression of classic Kaposi&#x2019;s sarcoma</article-title>
<source>Dermatology</source>
<year>1997</year>
<volume>194</volume>
<fpage>287</fpage>
<lpage>9</lpage>
</nlm-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="supported-by">
<p><bold>Source of Support:</bold> Nil</p>
</fn>
<fn fn-type="conflict">
<p><bold>Conflict of Interest:</bold> None declared.</p>
</fn>
</fn-group>
</back>
</article>